Vanessa Caceres | Authors


Immunotherapy’s Potential in Neuro-Oncology

November 18, 2014

A plenary session held November 15 at the Society of Neuro-Oncology’s (SNO) 2014 Annual Meeting in Miami Beach focused on immunotherapy’s promise as well as its challenges as a treatment for patients with brain cancer.

Rindopepimut Benefits Patients With EGFRvIII Mutation in Glioblastoma

November 16, 2014

The vaccine rindopepimut appears to benefit patients with epidermal growth factor receptor variant III mutation (EGFRvIII) in glioblastoma with regard to progression-free survival (PFS) and overall survival (OS).